ISL
NSPR icon

Ingalls & Snyder LLC’s InspireMD NSPR Stock Holding History

Ingalls & Snyder LLC’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$258K Sell
368,800
-10,500
-3% -$11.1K 0.01% 400
2026
Q1 		$618K Sell
379,300
-5,000
-1% -$8.53K 0.02% 260
2025
Q4 		$684K Buy
384,300
+159,298
+71% +$332K 0.03% 253
2025
Q3 		$542K Buy
+225,002
New +$546K 0.02% 290

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Ingalls & Snyder LLC's NSPR Position: Q2 2026 in Review

Ingalls & Snyder LLC reduced its InspireMD (NSPR) stake by 2.8% in Q2 2026, selling an estimated $11.1K and leaving 368,800 shares worth $258K. The position accounts for 0.01% of the portfolio, ranked #400.

Ingalls & Snyder LLC first reported a position in NSPR in Q3 2025 and has held it in 4 quarters since. The position peaked at $684K in Q4 2025. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Ingalls & Snyder LLC held 368,800 shares of InspireMD worth $258K as of Q2 2026.
  • Ingalls & Snyder LLC sold 10,500 InspireMD shares in Q2 2026, an estimated $11.1K.
  • InspireMD made up 0.01% of Ingalls & Snyder LLC's portfolio in Q2 2026, its #400 holding.
  • Ingalls & Snyder LLC first reported a position in InspireMD in Q3 2025 and has held it in 4 quarters since.
  • Ingalls & Snyder LLC's InspireMD position peaked at $684K in Q4 2025.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2026, filed 14 Aug 2026.